Melissa Bradford-Klug, MBA
CHIEF BUSINESS OFFICER, CITRINE MEDICINE
Belmont, Massachusetts, United States
Melissa completed her Bachelor of Science degree in Chemistry and earned her Master of Business Administration with an emphasis on Finance from DePaul University. She has also completed executive education courses at Kellogg School of Management, Harvard Business School, and Harvard T.H. Chan School of Public. She has led business operations across a variety of life sciences and pharmaceutical companies. Her notable achievements include transaction experience ranges from in-licensing, out-licensing, co-development, public company M&A, asset purchases and options agreements, resulting in over $5B worth of transactions that revitalized Mallinckrodt and AMAG Pharmaceuticals portfolios. She completed a merger of equal values with two publicly traded companies, Keryx and Akebia. Melissa has also in-licensed three drug development programs in the women’s health field as Chief Executive Officer of Mayfield Pharmaceuticals from 2019-2020.